In this context, where uncoupled eNOS contributes to increased ROS levels, LDL is oxidised to Ox-LDL, accelerating the development of atherosclerosis [38,42,47,48] by binding to its target receptor LOX-1 (Lectin-like oxidised low-density lipoprotein receptor-1). Here, OLR1 is linked to atherosclerosis.